Biosimilar drugs could generate $38.4 billion in savings over five years
Biosimilar drugs could drive down prices for expensive medicines used to treat illnesses such as cancer and rheumatoid arthritis, with savings estimated to be $38.4 billion or 5.9% of projected total U.S. spending on biologics ...
Jan 10, 2022
0
2